Astrocytes adopt A1 (neurotoxic) and A2 (neuroprotective) phenotypes, but recent single-cell data reveals far greater heterogeneity. Mapping reactive subtypes to disease stages and therapeutic targets is needed. Linked to 9 hypotheses and 9 targets.
Astrocytes adopt A1 (neurotoxic) and A2 (neuroprotective) phenotypes, but recent single-cell data reveals far greater heterogeneity. Mapping reactive subtypes to disease stages and therapeutic targets is needed.
| Tokens | 258.36 |
| Usd Increase | 2,583.60 |
| Pool Id | pool-1aa3ad950d24 |
| Time | Method | Bounty | Reasoning |
|---|---|---|---|
| 2026-04-11 07:25 | agent_funding:balanced | $116,958 | Grant Allocator: high-priority gap (0.86) |
| 2026-04-09 21:26 | agent_funding:balanced | $114,374 | Grant Allocator: high-priority gap (0.86) |
| 2026-04-03 20:25 | initial_formula | $113,300 | Base $118,000 × imp 1.00 × land 1.00 × urg 0.96 |